Generation of a Monoclonal Antibody Agonist to Toll-Like Receptor 5
BUFFALO BIOLABS, LLC · Department of Health and Human Services
Phase I2009$109,719
DESCRIPTION (provided by applicant): Systemic treatment with the bacterial flagellin protein, a Toll-like receptor 5 (TLR5) agonist, provides protection against high dose radiation through activation of nuclear factor-(…